Chronic Pelvic Pain with Dr. Insiyyah Patanwala | Evening Rounds: Ambulatory Lecture Series

Value of the Information & Strength of the Argument

The lecture provides valuable, up-to-date clinical insights into chronic pelvic pain, a condition often underdiagnosed and undertreated. Dr. Patanwala’s argumentation is solid, grounded in her clinical experience and supported by references to ACOG definitions, Nantes criteria for pudendal neuralgia, and a 2024 algorithm from the ‘green journal’ (likely Obstetrics & Gynecology). She effectively argues for a multifactorial approach, highlighting the interplay between gynecologic, musculoskeletal, and psychological factors. The emphasis on trauma-informed care and patient-centered communication is particularly valuable. However, some claims, such as the effectiveness of trigger point injections or the off-label use of medications, are presented without extensive evidence, reflecting the limited research in this area. Overall, the argumentation is persuasive and clinically relevant.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates scientific rigor through its structured approach and reliance on established definitions and criteria. Dr. Patanwala cites ACOG for the definition of chronic pelvic pain, Nantes criteria for pudendal neuralgia, and mentions a 2024 algorithm from the ‘green journal’ (likely Obstetrics & Gynecology) for pelvic floor dysfunction. She also references the 2015 ISSVD guidelines for vulvodynia classification. The sources are appropriate and credible, though specific citations are not provided in the video. The title accurately reflects the content, as it is a lecture on chronic pelvic pain within an ambulatory series. The content is well-organized and aligns with the stated objectives.

The title accurately reflects the content: a lecture on chronic pelvic pain by Dr. Patanwala, part of an ambulatory lecture series.

8/10

Presentation by a specialist in gynecologic surgery and pelvic pain, with evidence-based references to ACOG, Nantes criteria, and a 2024 algorithm from the 'green journal'. The content is clinically grounded, but some treatments are off-label and the lecture format limits depth.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction and objectives of the lecture.
• 05:00Overview of gynecologic and non-gynecologic causes of chronic pelvic pain.
• 10:00Definition and epidemiology of chronic pelvic pain, emphasizing multifactorial nature.
• 15:00Importance of trauma-informed care and patient consent in history and exam.
• 20:00Detailed history taking for pelvic pain, including OB trauma and musculoskeletal factors.
• 25:00Pelvic floor muscle spasm: signs, symptoms, and physical exam techniques.
• 30:00Treatment of pelvic floor dysfunction: physical therapy, dilators, suppositories, trigger point injections.
• 35:00Pudendal neuralgia: definition, causes, and diagnostic nerve blocks.
• 40:00Treatment options for pudendal neuralgia: physical therapy, medications, cryoablation, surgery.
• 45:00Vulvodynia: definition, types, and classification guidelines.

• ACOG definition of chronic pelvic pain — Referenced for the definition of chronic pelvic pain as pain lasting at least 6 months.
• Nantes criteria for pudendal neuralgia — Used to define pudendal neuralgia based on clinical criteria.
• 2024 algorithm in the 'green journal' (Obstetrics & Gynecology) — Cited as an algorithm for treating pelvic floor dysfunction, created with Dr. Kenton.
• 2015 ISSVD guidelines for vulvodynia classification — Referenced for the classification of vulvar pain and vulvodynia.

• ACOG Practice Bulletin on Chronic Pelvic Pain — Supports the definition and management approach discussed.
• International Pelvic Pain Society (IPPS) — Provides resources and guidelines on pelvic pain, aligning with the lecture's multidisciplinary approach.

• Some studies question the efficacy of trigger point injections — While the lecture supports trigger point injections, some literature suggests limited evidence for their long-term benefit.